17th Apr 2008 07:00
ReGen Therapeutics PLC17 April 2008 FOR IMMEDIATE RELEASE 17 April 2008 ReGen Therapeutics Plc ("ReGen" or the "Company") Issue of Shares As announced by ReGen Therapeutics Plc ("ReGen" or the "Company"), (AIM: RGT) on26 March 2008, ReGen has entered into a £2,000,000 equity credit facilityagreement with Duke Holdings Corporation Limited ("Duke") to provide a drawdownof monies in exchange for shares in the Company (the "Facility"). In accordance with the terms of the Facility and pursuant to a drawdown noticefrom the Company issued in March 2008, Duke has now subscribed for 325,000 newordinary shares at 23.8p per share. This will provide the Company with £77,350,before expenses. The 325,000 new ordinary shares, which will represent 2.83 per cent of theenlarged issued share capital of the Company (11,482,452 ordinary shares), willrank pari passu in all respects with the existing ordinary shares in theCompany. Application has been made to the London Stock Exchange for the new ordinaryshares to be admitted to trading on AIM and dealings in the new ordinary sharesare expected to commence on 22 April 2008. For further information, please contact: Percy Lomax ReGen Therapeutics Plc Tel: 020 7153 4920 Roland Cornish/Felicity Geidt Beaumont Cornish Limited Tel No 020 7628 3396 David Scott/Nick Bealer Alexander David Securities Limited Tel: 020 7448 9800 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
TILS.L